林 源峰

Medicine & Life Sciences

1. Neoplasm Metastasis 100%
2. Triple Negative Breast Neoplasms 92%
3. Down-Regulation 74%
4. Lung Neoplasms 73%
5. Chaperonin Containing TCP-1 54%
6. Neoplasms 53%
7. Glioma 52%
8. Clear-cell metastatic renal cell carcinoma 48%
9. Up-Regulation 47%
10. Type C Phospholipases 47%
11. Paclitaxel 46%
12. Autophagy 44%
13. Renal Cell Carcinoma 43%
14. phosphoserine aminotransferase 40%
15. Catenins 39%
16. Biomarkers 37%
17. Sertoli Cells 37%
18. Adenocarcinoma of Lung 35%
19. Tubulin 35%
20. Glioblastoma 35%
21. Colorectal Neoplasms 34%
22. Apoptosis 34%
23. Temozolomide 33%
24. Squamous Cell Carcinoma of Head and Neck 32%
25. Mechanistic Target of Rapamycin Complex 1 30%
26. Proteins 28%
27. Lactoferrin 26%
28. (1-methyl-1H-indol-5-yl)-(3,4,5-trimethoxy-phenyl)-methanone 26%
29. Head and Neck Neoplasms 26%
30. 2-dimethylamino-N-(1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl)acetamide 25%
31. Drug Therapy 25%
32. Proteolysis 24%
33. Genes 24%
34. Therapeutics 23%
35. Follicle Stimulating Hormone 23%
36. Mouth Neoplasms 23%
37. Lithium 22%
38. Non-Small Cell Lung Carcinoma 22%
39. Squamous Cell Carcinoma 21%
40. Drive 21%
41. Atlases 21%
42. Cell Line 21%
43. DNA polymerase theta 20%
44. Histones 19%
45. Follistatin-Related Proteins 19%
46. Nitric Oxide Synthase Type II 19%
47. Nanoparticles 18%
48. Mutation 18%
49. Peptides 18%